On 28-29 June 2023, the European Network for Sexually Transmitted Infections (STI) composed of epidemiological and microbiological experts nominated by European Union/European Economic Area (EU/EEA) countries met in Stockholm, Sweden. One of the sessions in this meeting was dedicated to the use of doxycycline for the prevention of bacterial STIs and was co-chaired by a principal expert antimicrobial resistance and healthcare associated infections at ECDC and the chair of the International Union against Sexually Transmitted Infections (IUSTI) Europe. The objectives of the session were: (i) to provide an update on the evidence of efficacy of doxycycline taken before, during, or after unprotected sexual contact in reducing the incidence of chlamydia, gonorrhoea and syphilis; (ii) to present considerations on the impact of the widespread use of doxycycline on antimicrobial resistance of bacterial STIs, other pathogens and commensals, and; (iii) to discuss the potential benefits and harms of doxycycline prophylaxis at individual and public health levels, with a focus on EU/EEA context. Presentations by two invited keynote speakers were followed by an interactive discussion session among the STI Network members led by the co-chairs.
Access the report from the meeting here.
Source : Eurosurveillance
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.